



Understanding, Controlling and Exploiting
Conformational Plasticity
Mariapina D’Onofrio , Francesca Munari and Michael Assfalg *
Department of Biotechnology, University of Verona, 37134 Verona, Italy; mariapina.donofrio@univr.it (M.D.);
francesca.munari@univr.it (F.M.)
* Correspondence: michael.assfalg@univr.it; Tel.: +39-045-8027939
Academic Editor: Pil Seok Chae
Received: 25 September 2020; Accepted: 27 November 2020; Published: 29 November 2020


Abstract: Alpha-synuclein (αS) is an extensively studied protein due to its involvement in a group of
neurodegenerative disorders, including Parkinson′s disease, and its documented ability to undergo
aberrant self-aggregation resulting in the formation of amyloid-like fibrils. In dilute solution, the protein
is intrinsically disordered but can adopt multiple alternative conformations under given conditions,
such as upon adsorption to nanoscale surfaces. The study of αS-nanoparticle interactions allows us to
better understand the behavior of the protein and provides the basis for developing systems capable of
mitigating the formation of toxic aggregates as well as for designing hybrid nanomaterials with novel
functionalities for applications in various research areas. In this review, we summarize current progress
on αS-nanoparticle interactions with an emphasis on the conformational plasticity of the biomolecule.
Keywords: alpha-synuclein; amyloid fibrils; conformational flexibility; protein adsorption; protein
aggregation; nano-bio interface; nanocomposite; nanoparticles; supramolecular assembly
1. Introduction
Alpha-synuclein (αS) is a paradigmatic and one of the most extensively investigated intrinsically
disordered proteins (IDPs) [1,2]. It is an abundant neuronal protein which localizes predominantly to
presynaptic terminals and binds to small synaptic vesicles [3]. The biological function of the protein
remains enigmatic, although increasing evidence supports its participation in neurotransmission
and synaptic plasticity, including roles in synaptic vesicle recycling and neurotransmitter synthesis
and release [4–6]. αS has also been reported to interact with and affect a variety of proteins [7].
Soon after its discovery, the protein became infamous for being strongly linked, genetically and
pathologically, to Parkinson’s disease (PD) and other neurodegenerative diseases characterized by
abnormal accumulation of insoluble αS deposits [8–10].
Encoded by the SNCA gene, αS is a 14-kDa polypeptide which can be broadly divided into
three domains: an amphiphilic N-terminal region (residues 1−60) that contains four imperfect
eleven-residue amino acid repeats, a hydrophobic, amyloidogenic domain (residues 61−95, referred to
as non-amyloid-β component, NAC, domain) with three additional repeats, and an acidic C terminus
(residues 96−140) [9,11]. In dilute solution, αS is unstructured and best described as a dynamic ensemble
of interconverting conformations [12–14]. Mounting evidence indicates that native oligomers exist
in cells, which exhibit greater aggregation resistance than the disordered monomeric species [15–18].
Environmental changes, binding events and other stimuli may promote the transition from the
soluble monomeric and small oligomeric states to higher-level oligomers, fibrils (highly ordered
supramolecular nanostructures) and amorphous aggregates [12,15,19,20]. The high protein solubility
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and the possibility to trigger conformational changes in vitro upon exposure to specific environments
and stimuli, have made αS a popular model for structural and aggregation studies of IDPs [1,21].
In the context of amyloidogenic, unfolded peptides and proteins like αS, nanoparticles (NPs) have
attracted interest as artificial receptors or chaperones against the formation of toxic aggregates [22].
NP surfaces, acting as a scaffold for protein adsorption, could provide the means to redirect aggregation
pathways, sequester/correct misfolded structures, retard or accelerate aggregation and disaggregate
assemblies. NPs are versatile platforms, they can be prepared in a wide range of sizes and with
diverse surface chemistries. In principle, by careful design of the NPs it should be possible to
control their interactions with biological components and develop artificial receptors capable of
biomolecular recognition [23–28]. Among the vast array of potential applications that rely on optimized
target recognition, NPs represent a promising alternative to conventional small drugs for targeting
protein-protein interactions associated with pathological conditions [24] and indeed have emerged as a
new class of therapeutics [29].
The nanometer scale of their size makes NPs able to interact with cellular systems and biomolecular
networks and to reach targets of biomedical interest [30]. Upon exposure to biological media, NPs tend
to be covered by a layer of biomolecules, generally consisting of an internal, long-lived layer (termed
hard corona) and a more loosely associated, external layer (termed soft corona) [30]. The protein corona
mediates the interactions with the living systems and determines the physiological responses [30,31].
Unintended protein adsorption onto NPs may perturb the protein’s activity as a consequence of
binding-induced changes in structure, stability or the exposure of recognition sites [32]. It is thus
essential to characterize both the structural and dynamic organization of the corona and the modes of
binding of distinct biomolecules to the NP surface [33].
The ability of ad-hoc prepared NPs to target and associate to specific proteins can be extended to the
development of novel hybrid materials composed of proteins and NPs, which feature unique attributes
not attainable with the separate components [34]. Protein-NP bioconjugation is an attractive method to
fabricate functional materials enabling applications in sensing, delivery and other nanotechnological
areas [34]. Protein molecules can be used to coat the NPs and protect them from the medium, to join
multiple NPs in order to form higher order supramolecular assemblies, they can be introduced into
hollow structures of the NPs or be surrounded by them [35]. The variety of conformational states of
certain disordered and self-aggregating proteins may be exploited to tune the properties of the hybrid
material to different purposes.
A number of groups have strived to elucidate the modes of binding of αS to simple NPs made by
different core materials, including silica, gold and lipids, which exhibit biocompatibility and can be
easily functionalized [36–38]. A variety of experimental and computational techniques were applied
to gain information at the molecular and sub-molecular level on the organization of αS molecules
within a hard corona, on the NP-induced structural transitions, the determinants of binding and the
dynamic exchange processes at the nano-bio interface. The possibility to perturb the aggregation
behavior of αS by use of NPs has attracted considerable interest [39,40]. Research efforts were largely
focused on the observation of aggregation kinetics curves of αS in the presence or absence of NPs,
providing insight into the aggregation process at the macroscopic level [41]. A mechanistic description
of the effects of NPs on the aggregation kinetics has lagged behind, however few reports have provided
preliminary insight into the microscopic events and structural conversions taking place during αS
aggregation [42–44]. Interestingly, certain NPs were shown to interact with and disassemble preformed
amyloid fibrils [40]. Tailored interactions between αS and NPs were further explored to develop
reactive agents and nanobiocomposites featuring novel attributes for application in nanotherapeutics,
nanooptics, nanoelectronics and other areas [45,46]. A large number of studies have been carried out to
explore how NPs bind to and influence the aggregation propensity of diverse amyloidogenic proteins
and peptides other than αS [22], however αS appears to have attracted greater attention than other
IDPs for developing composite nanomaterials, presumably due to its unique favorable properties,
such as molecular size, solubility, stability and ease of production.
Molecules 2020, 25, 5625 3 of 23
The objective of this review is to summarize progress made in the study of αS interactions
with NPs, with an emphasis on the conformational plasticity of the protein and its self-assembling
propensity. The review is divided into three sections discussing: (1) fundamental aspects and molecular
determinants of αS adsorption onto NP surfaces; (2) efforts aimed at controlling αS self-aggregation,
formation of toxic assemblies and disaggregation of insoluble fibrils; (3) achievements towards the
fabrication of αS-based hybrid materials presenting novel functionalities. We aim to provide the
basis for better understanding the conformational properties of αS at the interface with NPs and
illustrate how this knowledge may support our ability to control αS structural transitions and to design
functional nanocomposites. Among the large variety of known NPs, we decided to focus our survey
on the simplest type, namely particles of near-spherical shape. The selected case studies comprise both
inorganic and organic materials as well as lipid nanovesicles. While the former types are attractive
tools for exploratory purposes and applications, the latter are included for their great relevance
as biomembrane mimics to probe αS conformational versatility and membrane surface-induced
structural transitions.
2. Adsorption of Monomeric Alpha-Synuclein onto Nanoparticles
2.1. Silica Nanoparticles
The distinct physicochemical environment of the hard and the soft corona is expected to influence
differently the conformational preferences of protein molecules. Recent work by Grandori and
coworkers focused on the characterization of the conformations of αS and other proteins in the hard
corona of silica NPs (SNPs) [37]. To prepare corona-coated SNPs, SNPs (~50 nm) were incubated
with excess αS and then subjected to centrifugation and washing cycles. Based on transmission
electron microscopy (TEM) analysis, the αS corona was found to be formed by a monolayer of tightly
bound, collapsed molecules. Circular dichroism (CD) and Fourier-transform infrared (FTIR) spectra
suggested the formation of helical segments on adsorption of αS to SNPs, however the effect was
rather limited, indicating that the disordered state remained prevalent. Despite the limitations of the
single experimental techniques in the analysis of protein-NP hybrids, such as possible scattering effects
affecting CD experiments, the work demonstrated that a combination of them could provide useful
structural insights into adsorbed protein layers.
To complement the knowledge acquired on the hard corona, a subsequent study was aimed at
the characterization of αS molecules in dynamic exchange with the surface of SNPs [38]. Tira et al.
used nuclear magnetic resonance (NMR) spectroscopy to gain insight into the adsorption mechanism
at single-residue resolution. The direct observation of NMR signals from NP-bound proteins is
generally unfeasible due to excessive line-broadening caused by the slow rotational tumbling of the
hybrid species, however perturbations may be detected as intensity losses or exchange-averaged
observables [47,48]. Indeed, heteronuclear single quantum correlation (HSQC) spectra and relaxation
rate measurements performed on samples containing αS and SNPs revealed that the amphipathic
amino-terminal domain was the primary contact with the NP surface, while the carboxy-terminal
domain retained significant mobility (Figure 1A,B). An oxidized form of αS, containing four methionine
sulfoxides, associated with oxidative stress, was found to exhibit similar binding properties as the
unmodified species, indicating that the increased hydrophilicity did not influence the binding to SNPs.
Interestingly, αS interacted with the surface of SNPs also in the molecularly crowded environment of
blood serum with similar orientation as in simple buffer (Figure 1C). Additional competition binding
experiments, supported by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
analysis, showed that αS was able to displace serum albumin and other proteins from the surface of
NPs, while the highly basic four-repeat domain of Tau, an amyloidogenic IDP, displayed stronger
affinity to SNPs, compared to αS. Thus, αS adsorption was described as a dynamic process wherein
molecular exchange on the surface determines the composition and organization of the protein corona.
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Figure 1. Orientation of αS molecules on the surface of nanoparticles. (A–C) Site-resolved nuclear 
magnetic resonance (NMR) interaction profiles revealing amino acid residues of αS involved in 
binding to silica nanoparticles (SNPs) on the basis of intensity attenuations or increased nuclear spin 
relaxation rates. (A) Relative signal intensities obtained from heteronuclear single quantum 
correlation (HSQC) spectra measured on 15N-enriched αS dissolved in buffer solution, in the absence 
of SNPs (I0) or in their presence (I), at two different concentrations (gray and black bars). (B) 15N 
transverse relaxation rate values measured in the absence (gray dots) and presence of SNPs (green 
dots). (C) Relative HSQC signal intensities measured on 15N-enriched αS in human blood serum 
containing (I) and not containing (I0) SNPs. Adapted from ref. [38], Copyright 2020, with permission 
from Elsevier. (D,E) Rendering of simulated interaction of αS with AuNPs showing the reversed 
orientation of the protein depending on the capping ligand. (D) Interaction with citrate-capped 
AuNPs. (E) Interaction with MTAB-capped AuNPs. Citrate and MTAB ligands are charged 
(highlighted in red and blue, respectively). Adapted with permission from Lin et al. J. Phys. Chem. C 
Nanomater. Interfaces. 2015, 119(36), 21035–21043. Copyright 2015 American Chemical Society. 
The capability of nuclear magnetic resonance (NMR) spectroscopy to provide atomic-resolution 
information on protein-NP interactions and the qualitative observation that the binding of IDPs to 
certain NPs is related to the polypeptide sequence, stimulated Brüschweiler and coworkers to 
attempt a quantitative analysis of residue-specific NMR data. [49] The authors developed an 
interaction model based on a quantitative NP affinity scale determined from measurements on single 
amino acid types. In conditions of rapid exchange between free and surface-bound states, the 
difference in residue-specific 15N-spin transverse relaxation rate constants, 15N-R2, observed in the 
presence and absence of NPs, termed ΔR2, provides a direct measure of the interaction strength 
between the NP and residues in the polypeptide chain. After a number of refinements, the authors 
came up with a binding model capable to accurately predict residue-specific binding affinities of αS 
and other IDPs to SNPs. [50,51] This work provided mechanistic insight into the binding of αS and 
SNPs, explaining the observed interaction profile in terms of the non-uniform distribution of charged 
and neutral amino acids as well as in terms of global and local cooperativity effects. 
Overall, the binding of αS to SNPs appears as a simple reversible two-state binding mechanism 
mediated in large part by the lysine-rich N-terminal domain, which experiences attractive 
electrostatic interactions with the negatively charged, deprotonated silanol groups at the SNP 
surface. However, this simplified picture does not explain all observations, such as the apparently 
distinct involvement of the C-terminal domain at different protein/NP ratios and the formation of a 
Figure 1. Orientation of αS molecules on the surface of articles. (A–C) Site-resolved nuclear
magnetic (NMR) interaction profiles revealing amino acid residues of αS involved in bindi g
to silica nanop rticles (SNPs) on the basis of intensity atte uations or increased uclear spin r laxation
rates. (A) Relative signal intensities obtain d from heteronuclear single quantum correlation (HSQC)
spectra measured on 15N-enriched αS dissolved in buffer solution, in the absence of SNPs (I0) or in
their presence (I), at two different concentrations (gray a d black bars). (B) 15N transverse relaxation
rate values measured in the absence (gray dots) and presence of SNPs (green dots). (C) Relative
HSQC signal intensities measured on 15N-enriched αS in human blood serum containing (I) and
not containing (I0) SNPs. Adapted from ref. [38], Copyright 2020, with permission from Elsevier.
(D,E) Rendering of simulated interaction of αS with AuNPs sho ing the reversed orientation of the
protein depending on the capping ligand. (D) Interaction with citrate-capped AuNPs. (E) Interaction
with MTAB-capped AuNPs. Citrate and MTAB ligands are charged (highlighted in red and blue,
respectively). Adapted with permission from Lin et al. J. Phys. Chem. C Nanomater. Interfaces. 2015,
119(36), 21035–21043. Copyright 2015 American Chemical Society.
The capability of nuclear magnetic resonance (NMR) spectroscopy to provide atomic-resolution
information on protein-NP interactions and the qualitative observation that the binding of IDPs to
certain NPs is related to the polypeptide sequence, stimulated Brüschweiler and coworkers to attempt
a quantitative analysis of residue-specific NMR data [49]. The authors developed an interaction model
based on a quantitative NP affinity scale determined from measurements on single amino acid types.
In conditions of rapid exchange between free and surface-bound states, the difference in residue-specific
15N-spin transverse relaxation rate constants, 15N-R2, observed in the presence and absence of NPs,
termed ∆R2, provides a direct measure of the interaction strength between the NP and residues in the
polypeptide chain. After a number of refinements, the authors came up with a binding model capable
to accurately predict residue-specific binding affinities of αS and other IDPs to SNPs [50,51]. This work
provided mechanistic insight into the binding of αS and SNPs, explaining the observed interaction
profile in terms of the non-uniform distribution of charged and neutral amino acids as well as in terms
of global and local cooperativity effects.
Overall, the binding of αS to SNPs appears as a simple reversible two-state binding mechanism
mediated in large part by the lysine-rich N-terminal domain, which experiences attractive electrostatic
interactions with the negatively charged, deprotonated silanol groups at the SNP surface. However,
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this simplified picture does not explain all observations, such as the apparently distinct involvement of
the C-terminal domain at different protein/NP ratios and the formation of a slowly desorbing hard
corona [38]. Furthermore, the role of intermolecular interactions in the structural organization of the
protein corona have remained elusive. Diverse techniques have served to provide detailed descriptions
of the organization of folded protein molecules bound to NPs [52–54], however similar results were
not obtained for αS, likely due to the greater difficulty of obtaining clear data for an unstructured
polypeptide. All of these aspects deserve attention in future studies.
2.2. Gold Nanoparticles
The study of the adsorption of proteins to AuNPs has invariably involved the use of capped
or functionalized AuNPs. In an early work, Murphy and coworkers investigated the interaction of
αS with citrate-capped 20 nm and 90 nm AuNPs [55]. The authors used dynamic light scattering
(DLS) to monitor changes in the mean hydrodynamic diameter after mixing the protein with the NPs.
They observed the formation of a relatively thick, strongly bound adlayer (hard corona) and a less
thick, labile soft corona. An overall apparent binding constant of (2.0 ± 0.4) × 107 M−1 was estimated
from the DLS data using 20 nm AuNPs and a similar result was obtained from the analysis of plasmon
band maxima in the UV−vis spectra. Fluorescence quenching was exploited to separately quantify the
binding constants for the hard and the soft corona, yielding affinity constant values in the order of 107
M−1 and 10−3 M−1, respectively. The latter value suggested that the binding of the soft corona was
thermodynamically unfavorable and kinetically driven. The authors further attempted a structural
analysis of NP-bound protein by CD using a stacked double-cuvette method but realized that high
absorbance by the metallic core could compromise the quality of the obtained results. Therefore,
they resorted to use enzymatic digestion followed by mass spectrometry (MS) analysis to gain insight
into the structure of αS in the hard corona. A comparison of trypsin digestion patterns of free αS
with bound αS on 20 nm citrate-capped AuNPs suggested that the protein maintained its native
unstructured state when bound on AuNPs, with the N-terminal section strongly adsorbed onto the
NP surface.
As opposed to citrate-capped AuNPs, which expose a negatively charged surface, poly (allylamine
hydrochloride) (PAH) coated AuNPs display a positively charged surface. Murphy’s group used a
similar methodology as that used with citrate AuNP to explore the structure of αS bound to PAH
AuNPs [36]. The protein was found to adsorb as multilayers when present at low protein/NP ratios
and eventually formed agglomerates at higher ratios. The latter condition was attendant with an
increase in β-sheet structure and decrease in α-helical content, possibly explaining the tendency to form
agglomerates. Apparently, the mode of adsorption could elicit the seeding of a global conformational
change of αS in the sample. Based on trypsin digestion data, the protein molecules were found to
adopt random orientation in the multilayered corona.
Solution NMR spectroscopy was used in a subsequent study to obtain definitive insight into
the orientation of αS on both anionic and cationic AuNPs [56]. For cationic particles, in spite of
using PAH, AuNPs were capped with (16-mercaptohexadecyl) trimethylammonium bromide (MTAB),
a ligand that did not promote protein aggregation and therefore allowed better interpretation of
the NMR data. As expected, portions of the protein that bound to NPs exhibited larger linewidths
and attenuated signals. A comparison of the residue-by-residue intensity profiles collected with the
anionic and cationic NPs clearly showed the reverse orientation of the protein, with the prevalently
basic N-terminus acting as the anchor to citrate-capped AuNPs and the acidic C-terminus being
prevalently bound to MTAB AuNPs. Besides identifying the sections in direct contact with the NPs’
surfaces, the NMR data also revealed that the unanchored portions experienced restricted motion due
to their tethered condition. In both cases, the protein remained disordered upon binding to the NPs.
Molecular dynamics (MD) simulations supported the observed reversal of protein binding orientation
(Figure 1D,E) and additionally indicated that the central hydrophobic segment, the NAC domain,
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was attracted to both types of AuNPs. These results demonstrated the possibility to obtain molecular
control of protein display on engineered NPs.
2.3. Lipid Nanovesicles
In cells, αS partitions between disordered or partly ordered cytosolic forms and
phospholipid-bound states [57–59]. The association ofαS with phospholipid membranes was linked to a
role of the protein in the regulation of reserve pools of synaptic vesicles and dopamine homeostasis [6,60].
Such crucial function has spurred the investigation of αS binding to lipid nanovesicles as membrane
mimics. The N-terminal 11-mer repeat sequence of αS, resembling the sequence motifs found in
apolipoprotein A-I, suggested that it could form amphipathic helical lipid-binding domains [61].
Indeed, several in vitro studies have established that αS undergoes a coil-to-helix transition when
binding to vesicles made by acidic phospholipids or anionic detergents [61–63].
In studies ofαS-lipid interactions, a large variety of lipid/detergent vesicles of different composition
and size have been used and several distinct experimental conditions were tested, which may in part
account for the fact that results were sometimes seemingly contradictory [2,64]. The increase in helical
content on binding of αS to anionic phospholipid vesicles was initially observed by CD spectroscopy
and the interaction was proposed to be mediated by four N-terminal helices (region 1–60) [61]. In a
subsequent study, Eliezer and coworkers used small (~5 nm) SDS detergent micelles as membrane
mimics in place of larger phospholipid vesicles to facilitate observation of the lipid-bound state by
NMR spectroscopy [12]. They found that binding of α-synuclein to SDS micelles elicited formation of
an extended α-helix encompassing residues 1–100, while the C-terminal portion of the protein remained
unassociated. Later investigations, based on NMR and partial tryptic digestion, identified a short
break within the extended helical region [63,65]. Furthermore, spin probe-induced broadening of NMR
signals, 15N relaxation measurements and fluorescence spectroscopy data indicated the presence of two
N-terminal helices, positioned on the surface of the SDS micelle and separated by a flexible stretch [66].
The region of residues 61–95 was found to adopt a helical conformation but it was proposed to be
partially embedded in the micelle [66]. Finally, a high resolution structural determination established
that micelle-bound αS forms two curved α-helices within the N-terminal domain, connected by an
ordered, extended linker in an anti-parallel arrangement, followed by another short extended region
and a largely disordered tail (residues 98–140) [67].
SDS micelles have provided an invaluable system to study structural properties of lipid-bound
αS, however both the chemical composition and the size do not entirely recapitulate the features
of the ~50 nm presynaptic phospholipid vesicles. Thus, several studies have been conducted using
either small or large unilamellar vesicles (SUVs or LUVs). A structural model of SUV-bound αS was
obtained by applying simulated annealing MD restrained by the immersion depths and long-range
distances obtained from continuous-wave and pulsed electron paramagnetic resonance (EPR) data [68]
(Figure 2). The bound form was described as an extended helix (ca. 90 amino acids long) with a curved
arrangement that follows the curvature of the vesicle surface and allows lysine residues to interact
with phosphate groups, acidic residues to approach the choline groups and hydrophobic residues to
associate with the lipidic moieties. Further experimental evidence, based on single molecule Förster
resonance energy transfer and on the use of 100 nm LUVs, supported the extended helix model [69],
however other authors concluded that the broken-helix arrangement best described the SUV-bound
protein state [70]. Later studies provided evidence for coexisting populations of broken and extended
helices, in part reconciling the divergent models [71,72]. It was found that relative protein/lipid
concentrations and vesicle size could modulate the preference of αS for distinct helical arrangements. A
multiplicity of coexisting binding modes were further proposed by Bax and coworkers, featuring slow
exchange kinetics and involvement of N-terminal segments of differing length [73].
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Figure 2. Interaction of αS with curved lipid surfaces. (A) Space-filled model of α-synuclein (shown 
in green) binding to the surface of a lipid vesicle 300 A in diameter; ≈ 25% of the outer leaflet of the 
vesicle is shown. The vesicle was fitted around one of the structures derived from the experimentally 
restrained simulated annealing—molecular dynamics (SAMD) calculations. (B) A closer cross-
sectional view of the αS interaction with the lipid surface, with rotation through 90° from the image 
in A. The protein (green) follows the curved surface of the vesicle, with the helical axis positioned just 
below the level of the phosphate groups of the lipids. This position of the protein emerged from the 
SAMD calculations and reflects the immersion depths obtained from the continuous-wave electron 
paramagnetic resonance (EPR) data. (C) Cartoon representations of the structures of α-synuclein on 
micelles and small unilamellar vesicles (SUVs). The small and highly curved micelles cannot 
accommodate the extended helical structure present on the membrane. Adapted with permission 
from Jao et al., Proc. Natl. Acad. Sci. USA, 2008, 105 (50) 19666–19671. Copyright 2008 National 
Academy of Sciences. 
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anionic lipids versus neutral molecules [74]. Additionally, the degree of saturation and the length of 
the acyl chains were found to influence the binding of αS [75,76]. More specifically, molecular 
properties that determine the lipid phase state and membrane fluidity critically influence αS 
adsorption [74]. Interestingly, αS and anionic phospholipids may also form nanometer-sized 
lipoprotein particles, reminiscent of high-density lipoproteins, in which αS adopts a helical secondary 
structure [77]. Thus, the specific lipid environment has a profound impact on the partitioning and 
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2.4. Mixed-Type and Other Nanoparticles 
The widely documented attraction of synuclein to lipid layers has inspired the development of 
lipid-based composite particles, other than simple vesicles. For example, Lee and coworkers used 
osmotic shock to coat monodisperse SNPs (60 nm diameter) with a lipid membrane, thereby 
obtaining spherical NP-supported lipid bilayers (SSLBs) [78]. Specifically, SNPs were amine-
functionalized and the lipid coating was made by a mixture of the anionic lipid DOPA (1,2-dioleoyl-
sn-glycero-3-phosphate) and the zwitterionic lipid DOPC (1,2-dioleoyl-sn-glycero-3-
phosphocholine). SSLBs offer important advantages over SUVs/LUVs as they display larger X-ray 
scattering cross section of the silica core relative to membranes, enabling small-angle X-ray scattering 
(SAXS) and state-of-the-art X-ray photon correlation spectroscopy (XPCS), thereby expanding the 
repertoire of experimental techniques available to probe colloidal structure and dynamics of αS-
Figure 2. Interaction of αS with curved lipid surfaces. (A) Space-filled model of α-synuclein (shown
in green) binding to the surface of a lipid vesicle 300 A in diameter; ≈ 25% of the outer leaflet of the
vesicle is shown. The vesicle was fitted around one of the structures derived from the experimentally
restrained simulated annealing—molecular dynamics (SAMD) calculations. (B) A closer cross-sectional
view of the αS interaction with the lipid surface, with rotation through 90◦ from the image in A.
The protein (green) follows the curved surface of the vesicle, with the helical axis positioned just
belo the level of the phosphate groups of the lipids. This position of the protein e erged fro the
S calculations and reflects the immersion depths obtained from the continuous-wave electron
para agnetic resonance (EP ) data. (C) Cartoon representations of the structures of α-synuclein
on micelles and small unilamellar vesicles (SUVs). The small and ig ly c rve icelles cannot
accommodate the extended helical struct re present on the membrane. Adapted with permission from
Ja et al., Proc. Natl. Acad. Sci. USA, 2008, 105 (50) 19666–19671. Copyright 2008 National Academy
of Sciences.
espite the co plexit of lipid vesicle binding, consens s as reached about the preferential
interacti ith anionic phospholipids, although on-electrostatic interactions with neutral
and zwitterionic lipids were also observed. A systematic study p rformed with phospholipid
bilayer nanodiscs, an lternative mode of lipid embran s exhibiting planar surfaces, fi the
electrostatic odel and sho ed that the binding ode as dependent on the relative abundance of
anionic lipids versus neutral molecules [74]. Additionally, the degree of saturation a d the length of the
acyl chains were found t i fluence th binding of αS [75,76]. More specifically, mole ular prop rties
that de ermine the lipid phase state and m mbrane fluidity critically influence αS adsorption [74].
Interestingly, αS and anio ic phospholipids may als form nano eter-sized lipoprotein pa ticles,
reminisc nt of high-density lipopr teins, in which αS adopts a helical secondary tructure [77]. Thus,
the specific lipid environment has a profound impact on the pa titioning and onformational transitio s
of αS, suggesting the possibility to tune molecular properties and regulate biomolecular and nano-bio
interactions by careful design of the lipid-based nanomaterials.
2.4. ixed-Type and Other Nanoparticles
The idely docu ented attraction of synuclein to lipid layers has inspired the develop ent of
lipid-based co posite particles, other than si ple vesicles. For exa ple, Lee and co orkers used
os otic shock to coat monodisperse SNPs (60 nm dia eter) with a lipid membrane, thereby obtaining
spherical NP-supported lipid bilayers (SSLBs) [78]. Specifically, SNPs were amine-functionalized and
the lipid coating was made by a mixture of the anionic lipid DOPA (1,2-dioleoyl-sn-glycero-3-phosphate)
and the zwitterionic lipid DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine). SSLBs offer important
advantages over SUVs/LUVs as they display larger X-ray scattering cross section of the silica core
relative to membranes, enabling small-angle X-ray scattering (SAXS) and state-of-the-art X-ray photon
correlation spectroscopy (XPCS), thereby expanding the repertoire of experimental techniques available
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to probe colloidal structure and dynamics of αS-bound vesicles. The authors reported that αS disrupted
vesicle-vesicle interactions, with implications for synaptic membrane fusion and the ultrastructure and
dynamics of synaptic vesicle pools.
The coating of inorganic NPs with lipid layers was also recently pursued by other groups [79].
The surface of AuNPs of varying size was capped with an inner layer of dodecanethiol and an outer
layer of SDS. Thus, the organic bilayer was formed on a rigid scaffold and was resistant to deformation
by αS, as opposed to lipid vesicles which are known to undergo structural remodeling upon interaction
with the protein. By removing the effect of NP deformation, the obtained mimics allowed investigating
the effects of NP curvature on protein binding behavior. SDS-AuNP—bound αS displayed increased
solvent accessibility in the NAC region, suggesting that the adsorbed protein could possess higher
aggregation propensity than unbound αS.
In the study of potential applications of NPs as protein aggregation modulators, Hajipour and
coworkers focused on the interaction between αS and graphene sheets and superparamagnetic iron
oxide NPs (SPIONs) with different surface properties and sizes [44]. Graphene sheets were prepared
as small (150–250 nm), medium (450–650 nm) and large (800–1200 nm) sheets with polyglycerolsulfate,
polyglycerol and polyglycerolamine coverages, displaying surface charges of −30 mV, 0 and +30
mV, respectively. The investigated SPIONs were 20, 50 and 100 nm large and displayed various
functionalities (COOH, NH2, PEG-300 and chitosan). Atomistic MD simulations indicated that the
interaction of αS with charged nano-objects was initially driven by electrostatic attraction, with a later
involvement of hydrophobic residues and non-polar contacts dominating the interaction. Additionally,
hydrogen bonds were formed, particularly in the case of amine-functionalized graphene. Differences in
αS binding behavior to graphene and SPIONs were attributed to the distinct shape and corresponding
surface curvature of the two materials. The affinity to neutral nano-objects was lower compared
to charged ones. The various binding contributions resulted in distinct orientations of αS on the
surface of different particles, supporting the view that distinct nanomaterials could differently affect
αS self-assembly at the nano-bio interface.
Given the application of human serum albumin (HSA) NPs as carriers for drug delivery into the
brain, HSA NPs were studied by Otzen and coworkers in order to assess the nature of their interaction
with αS [80]. HSA NPs were produced as unmodified or polyethyleneimine(PEI)-functionalized
~35–40 nm spherical particles. By use of a centrifugation assay, fluorescence anisotropy measurements
and small-angle X-ray scattering (SAXS) data, the authors found that αS was attracted much more
strongly to positively charged PEI-HSA NPs than to negatively charged HSA NPs. Changes in the CD
spectral shape suggested that the interaction with PEI-HSA NPs caused a conformational change in αS.
The absence of a significant binding to HSA NPs, despite their net negative surface charge, may suggest
that interactions with biological NPs are distinct relative to most synthetic platforms because the
former exhibit an inhomogeneous distribution of polar, charged and nonpolar groups as opposed to
the generally isotropic presence of chemical groups on the surface of common synthetized NPs.
3. Influence of Nanoparticles on Alpha-Synuclein Aggregate Formation
3.1. General Surface Effects on Aggregation Kinetics
αS fibrillation is commonly considered a nucleation-dependent growth process that follows
sigmoidal kinetics with distinct phases of nucleation, propagation and equilibration [81,82] (Figure 3A,B).
The primary nucleation step (commonly associated with the lag-phase), during which soluble species
are sequestered into oligomers of different sizes and structures, is much slower compared to the
addition of monomers to preformed protofibrils, which leads to an exponential growth of fibrils
(growth, propagation or elongation phase) until a state of equilibrium is achieved (plateau phase).
This simplified two-step model adequately describes the evolution of the system from a macroscopic
point of view, however it does not consider the multitude of microscopic events that contribute to the
entire process. It is now established that simultaneous microscopic processes are ongoing during all
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phases and that processes other than primary nucleation and growth, such as fibril fragmentation
or secondary nucleation, may represent important events during aggregation [83–85]. On-pathway
and off-pathway intermediate supramolecular assemblies exhibit different degrees of cytotoxicity,
however their identification and characterization remains challenging [81,86]. Due to the complexity
of the aggregation phenomenon and the difficulty to access microscopic events, most studies involving
perturbations of αS aggregation focus on comparative analyses of the kinetics at the macroscopic
level. Experimentally, kinetics curves are generated by following time-dependent changes in sample
turbidity or the fluorescence intensity of fibril-responsive dyes, such as Thioflavin T or by means of
several other biochemical and biophysical techniques [21].
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Surfaces have a profound impact on aggregation pheno ena [42,87]. It has long b en recognized
that embrane surfaces can act as c talysts of fibril formati n, serving as a platform for nucleati n
and further polymerization [88,89]. Actually, membrane binding of αS appears to be an import t
factor i the pathogenesis of Parkin on’s disease [90]. Membrane-assisted aggrega ion could result
from s veral concurr nt factors, including a red ct on of conformational entropy in the b und s ate,
the induction of str ural ordering, surface molecul r crowding effects a d lowering of the local
diel ctric constant which may facilitate the formation of intermolecular conta ts [91–93]. The notion
t at surfaces may ilitate fibril formation is frequently exploited in in vitro aggregation studies of
certain IDPs, including αS, which display extremely slow aggregation kinetics n solution. The add tion
of beads or other surfaces impa t a dramatic acceleration on protein self-assembly, allowing to perform
experiments in practical t frames. Fibril seeds them elves off r particularly active surfa es that
catalyze nucleation of aggregation-resistant proteins. Ba ed on thes evidences, NPs have attra ted
muc interest owing to their high surface-to-volume ratio [94], compared o bulk material and many
studies h ve bee carried out on the ffe ts of NPs on the aggrega ion of amyloidogenic proteins [22].
It emerges that NPs can lead to either acceleration or r tardation of the fib il f rmation, epending on
several fac ors such as the phy icochemical properties of t e NPs (e.g., size, charge, nature of exposed
ch mical groups), the amino acid composition and stabil ty of the IDP, the c centrations of the solutes
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and the characteristics of the solution (e.g., ionic strength, pH) [95]. Thus, proper tuning of the NP
properties shows promise as a means to control fibril formation pathways and could eventually provide
a novel strategy for therapeutic intervention against aberrant protein aggregation in neurological
disorders. Nonetheless, it must be considered that NP properties will also determine their ability
to cross the blood-brain barrier and the cellular membranes before reaching the neuronal cytosol.
Available pathways and strategies adopted to deliver NPs across the blood-brain barrier have been
recently reviewed [96] and significant progress has been made in understanding the factors that control
cellular uptake of NPs [97,98]. Most of the case studies presented here aimed at probing specific surface
effects on protein aggregation and often did not address the ability of NPs to cross biological barriers.
A growing number of NP materials have been tested for their capability to influence the fibril
formation process of αS. They include metals (Au, Fe) [41,99,100], metal/metalloid oxides (CeO2, TiO2,
ZnO, Fe3O4, SiO2) [37,38,44,101–104], carbon (graphene, fullerenol) [44,105,106], polymers (dendrimers,
others) [42,107–111], biomolecules (protein-based) [80,112] and lipids (detergent, phospholipid) [74,
113–115]. The diversity of sizes, surface groups, charge density, hydrophobicity/hydrophilicity and
other features of the investigated particles, render the rationalization of the results a challenging task.
For example, both negatively and positively charged NPs were reported to inhibit αS fibrillation
and both types were found to accelerate the process. In this regard, it appears that in order to
establish more general paradigms, studies on a single protein/NP pair are of limited use, while more
systematic investigations would be more informative. Furthermore, we emphasize the importance of
conducting kinetics experiments with extreme rigor (e.g., avoiding NP precipitation, performing several
replicas) and of carefully reporting the conditions in which experiments were performed (solution
conditions, solute concentrations, mechanical agitation, etc.), to ensure that results can be compared
and interpreted correctly.
A systematic study of the interaction between αS and citrate-capped AuNPs in a range of sizes
(10, 14 and 22 nm) and of concentrations was carried out by Stefani and coworkers [41]. To monitor
the evolution of the aggregation process at a macroscopic level, the team adopted an approach based
on the use of the environment-sensitive fluorescent probe MFC, covalently attached to an engineered
αS. This dual-emission dye is a multiparametric fluorescent probe, highly sensitive to changes in
polarity and hence an exquisite reporter of early protein aggregation events [116]. The aggregation
kinetics of αS in the presence of NPs followed a sigmoidal trend, exhibiting a transition halftime that
decreased with the increase of AuNP concentration (Figure 3C). The overall acceleration produced by
the AuNPs could be traced back to distinct effects on the nucleation and growth phases. For smaller
AuNPs, the growth rate increased with particle concentration, while such effect was not observed with
the 22 nm AuNPs. Instead, the latter had a more pronounced effect on the duration of the lag phase.
The observed effects on the transition halftime and the growth rate did not scale with the available
surface area. The authors attributed the reduction of the lag phase to the accumulation of protein on
the AuNP surface, promoting the formation of critical nuclei for fibrillization. They further explained
the variations in growth rate as a function of AuNP size by the formation of nuclei of different nature.
This study therefore illustrates that the impact of NPs on the aggregation of αS is often not linear with
some property of the NPs but multifaceted, underscoring the complexity of microscopic interactions
occurring at the nano-bio interface.
3.2. Mechanistic Insights into Nanoparticle-Mediated Perturbations of αS Aggregation
A mechanistic description of the effects of surfaces on the aggregation kinetics of polypeptides
requires consideration of the concurring microscopic events. In this respect, several available strategies
may prove useful, such as the global analysis of macroscopic aggregation curves measured under
different conditions [117], computational methods that take into account the structural plasticity of the
polypeptide as well as the nature of the NP surface [117,118] and experimental procedures that allow
the observation of structural transitions or the detection of transient intermediates. To date, a limited
number of such studies have been applied to αS/NP systems.
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The consideration that certain NPs accelerate protein aggregation, while others cause a retardation
of fibril formation, prompted Linse and coworkers to explore which factors were responsible for one
or the other behavior [42]. By use of a dynamic Monte Carlo method, the group simulated amyloid
growth profiles in the presence of surfaces with varying attraction potential. The results showed that
weakly attractive surfaces (peptide binding constant, K = 0.0017 µM−1) determined a reduction of the
nucleation rate, compared to non-attractive surfaces, while highly attractive surfaces (K = 0.16 µM−1)
accelerated the nucleation process. Indeed, weakly attractive objects simply reduce the concentration of
free monomers available to form aggregation nuclei in solution but they do not change the microscopic
events. By contrast, on the surface of highly attractive materials, distinct nuclei are formed in addition
to those that form in solution. In the case of an intermediate attraction potential, the apparent kinetics
was similar to that occurring with non-attractive surfaces, however the structures of the initial aggregates
were different. Interestingly, the above observations were modulated by the intrinsic properties of the
polypeptide, whereby for example weakly attractive surfaces retarded fibril formation by aggregation-prone
mutants but accelerated the process for more stable polypeptides. ThT fluorescence assays performed using
plain polystyrene NPs and αS consistently showed an acceleration of fibril growth upon increasing NP
concentration, as a consequence of a strong non-electrostatic attraction causing surface-catalyzed nucleation.
In general, it seems possible that positively and negatively charged NPs could exert the same inhibitory or
acceleratory effect on the fibrillization of αS, because they would establish electrostatic interactions with
either the acidic C-terminal or the basic N-terminal domains [56]. Neutral objects were reported to have
limited impact on the aggregation rate, presumably because they were not able to interact significantly
with αS [44].
While computational methods can capture the formation of early-stage aggregates and provide
atomistic insights into conformational transitions with relative ease, the identification of transient
intermediates and the detection of time-dependent structural changes during fibrillization remain
experimentally challenging. Chattopadhyay and coworkers applied fluorescence correlation
spectroscopy (FCS) and laser scanning microscopy (LSM) to investigate the early events of αS
aggregation in the presence of pristine or Lys-modified Fe3O4 NPs [43]. The use of these techniques
proved advantageous over the use of standard dye-based methods which are quite insensitive
to the formation of smaller aggregation intermediates. Bare Fe3O4 NPs were found to accelerate
early and late-stage aggregation of αS, while Lys-coated Fe3O4 NPs displayed an inhibitory effect.
Maximum entropy analysis of the correlation functions measured by FCS detected increases in
conformational heterogeneity during the progress of aggregation and revealed the presence of
aggregated species at earlier time points in the presence of bare Fe3O4 NPs. The early aggregates were
visualized by LSM. The molecular basis for the different perturbations elicited by bare and Lys-coated
particles remains elusive, however the study demonstrated the possibility of acquiring important
information on aggregates in heterogeneous systems.
Hajipour and colleagues used size exclusion chromatography coupled with multi-angle light
scattering (SEC-MALS) to quantify the amount of small αS oligomers formed in the presence of
SPIONs or graphene nanoobjects and ranked the particles according to their ability to trigger the
formation of such aggregates [44]. They were further able to determine whether the formed oligomers
were on- or off-pathway with respect to fibrillization. In another study, Tira et al. followed the time
course of αS aggregation in the presence of SNPs using CD spectroscopy [38]. The authors could
track the time-dependent structural transitions of the polypeptide from its native disordered state
to conformations with mixed α and β secondary elements. Interestingly, the shapes of CD spectra
collected at different time points for αS and its methionine-oxidized form in the presence of SNPs
indicated that the two species formed distinct supramolecular assemblies, consistent with the reported
resistance of the oxidized species to form fibrils [119]. Taken together, the information obtained from
experiments on prefibrillar species could be used to inform computational methods and contribute to
an improved description of the complex aggregation pathways.
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3.3. Lipid Surface-Mediated αS Aggregation
The nature of lipid surfaces is quite unique due to their soft, dynamic character which allows
peptides to penetrate into the lipid layer(s), at least partially [120,121]. In addition, lipids and
amyloidogenic polypeptides share an amphipathic structure and are therefore intrinsically prone
to interact. The interactions are modulated by several factors and are highly dependent on lipid
composition, surface charges and thermotropic properties [122,123]. Hence, the mechanisms by
which lipid nanovesicles affect αS fibril formation may depart from those involved with other
nanomaterials. Indeed, the mode of association with lipid surfaces modulates αS aggregation in
different ways [91,115,124,125]. Furthermore, it has been suggested that fibrillization in the presence
of lipid molecules may result in the formation of protein-lipid co-aggregates [126–128] and that the
morphology of fibrils is modulated by the relative proportion of protein and lipids [129].
αS partitions dynamically to SUVs and LUVs composed of anionic phospholipids such as
phosphatidylserines [39,123]. Interestingly, the binding affinity is highest when the lipid layers are in
the fluid state, as opposed to the gel-like state, since in the former case the hydrophobic portions of the
lipid molecules are on average more exposed [123]. In turn, αS binding affects the lipid phase behavior
and induces lipid segregation into protein-poor and protein-rich populations [123]. Yet, unexpectedly,
the lipid phase state does not correlate with the vesicle-promoted acceleration of αS amyloid fibril
formation [123]. Instead, the kinetics of aggregation was found to correlate with the solubility of the
lipid molecules, suggesting that at least part of the free energy barrier for the aggregation process is
associated with the translocation of lipid molecules from a membrane to a protein environment [123].
Aggregation assays carried out under quiescent conditions and at varying dimyristoyl
phosphatidylserine (DMPS)/αS ratios indicated that αS did not convert into fibrils when excess
lipid was present and most of the protein was in the bound state [39]. On the contrary, at lower lipid
concentrations, when significant populations of both free and lipid-bound protein were established,
SUVs determined the rapid formation of amyloid fibrils. Indeed, a combined experimental and
theoretical analysis indicated that at low lipid/αS ratios, the bound protein promoted a primary
nucleation process, much faster than that occurring in bulk solution. The facilitated nucleation was
attributed to the high local concentration of protein on the SUV surface and to a conformational
shift towards aggregation-competent states [39]. Under the used conditions, other microscopic
processes, including homogeneous primary nucleation, secondary nucleation and fragmentation,
did not contribute measurably to the aggregation reaction. A similar finding was reported concerning
the effect of nanovesicles made by zwitterionic lipids, which influenced the lag time more than the
fibril elongation rate [113]. Under quiescent conditions, secondary processes may be prevented due to
kinetic trapping of the lipid-bound fibrils [39]. Site-resolved NMR data obtained using nanodiscs as
membrane models indicated that region-specific membrane affinities (particularly of the NAC region)
were correlated with aggregation behavior [74]. The dual effect of lipid surfaces to both accelerate or
inhibit αS amyloid fibril formation depending on the relative proportion of protein and phospholipids
may suggest a possible mechanism for the onset of aberrant aggregation as a consequence of altered
levels of αS expression, associated with some forms of PD [130].
It has been proposed that the transient interaction of αS with lipid bilayers may determine the
formation of a pool of helical conformers that are aggregation-resistant [131]. Thus, physiologically,
lipid surfaces may act as chaperones that assist the folding process of otherwise disordered protein
molecules. An imbalance in the relative populations of protein in the folded and unfolded pools may
cause aberrant aggregation in pathology. These findings suggest the possibility to develop tailored
NPs as artificial cofactors that assist the formation of aggregation-resistant αS species.
3.4. Nanoparticle-Fibril Interactions and Fibril Disassembly
The removal of amyloid deposits is a prominent therapeutic aim in protein misfolding diseases [132].
However, the disassembly of preformed amyloid fibrils is both challenging and risky. On the one
hand, protein fibrils are insoluble, extremely stable and resistant to degradation. On the other hand,
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disaggregation may exacerbate amyloid toxicity by increasing the load of toxic oligomers [133]. Thus,
in order for NPs to be effective in reverting aberrant deposition of protein fibrils, they must display
significant affinity for the fibrillar structures, establish interactions that weaken or disrupt the dense
network of hydrogen bonds that stabilize the stacked β-strands and promote the conversion of
fragments into harmless products. Diverse NPs were shown to interact with preformed αS fibrils.
Citrate-capped AuNPs of the size of 22 nm but not of 14 nm and lower, were found to associate
with fibrils, indicating a size-dependent affinity [41]. Mercapto-undecanesulfonate-coated AuNPs were
developed to target synthetic, recombinant and native fibrils derived from different amyloidogenic
proteins, including αS [134]. Such particles did not exhibit fibril-disaggregating properties, instead they
were exploited to label amyloid fibrils for assessing morphological polymorphism using cryogenic
electron microscopy (cryo-EM) [134]. Both SPIONs and graphene were reported to disassemble αS
fibrils, with a higher efficacy shown by positively charged nano-objects, possibly related to their higher
affinity to charged αS residues [44]. Upon fibril fragmentation, the amount of oligomeric species did
not increase, suggesting a safe use of these NPs [44].
In addition to graphene, also graphene quantum dots (GQDs) were shown to induce dissociation
of αS fibrils [40]. Ko and coworkers carried out a thorough characterization of this process [40].
GQDs produced the dissociation of fibrils into short fragments of an average length of 235 nm and
70 nm after 6 and 24 h, respectively. After 3 days of incubation, the number of fragments decreased,
indicating that the process progressed until complete disassembly. The interaction of the negatively
charged GQDs with αS was likely initiated by electrostatic attraction with the protein’s N-terminal
domain. MD simulations performed with the sole NAC domain indicated that after initial binding,
the β-sheet structure of the outer monomer was rapidly and completely destroyed as a consequence
of strong hydrophobic interactions between GQDs and valine residues. Importantly, GQDs could
penetrate the blood-brain barrier and protect mice against dopamine neuron loss induced by preformed
amyloid deposits.
Dendrimers have been recognized as potential powerful agents for the disaggregation of fibrils,
displaying strong binding affinity to fibrillar structures and exerting their destructive effect by acting as
efficient chaotropes [135]. Specifically, polyamidoamine (PAMAM) dendrimers were shown to interact with
αS fibrils, the binding affinity increasing with the generation number (G4 < G5 < G6) [109]. The combined
evidence from TEM, CD and ThT fluorescence indicated that dendrimers attacked the fibrils along the
entire filament, not just at the ends and lead to amorphous aggregation. Similar to PAMAM dendrimers,
also urea(U)- and methylthiourea(MTU)-modified polypropyleneimine (PPI) dendrimers were found
to disaggregate preformed fibrils [136]. TEM detected the fragmentation of fibrils by G3-MTU-PPI into
smaller and less organized aggregates. Interestingly, both types of NPs were found to significantly reduce
the αS fibril load inside SK-MEL-5 cells in a dose-dependent and generation-dependent (MTU-PPI) or
generation-independent (U-PPI) manner. However, MTU-PPI dendrimers displayed higher cytotoxicity in
the presence of preformed αS fibrils [136]. Further studies on the effects of dendrimers and other polymeric
particles on αS aggregation have been reviewed elsewhere [137].
4. Alpha-Synuclein/Nanoparticle Conjugates and Hybrid Nanomaterials
Functionalization or the combination of NPs with αS molecules has been intensely explored
to produce nanobioconjugates and hybrid nanomaterials for diverse technological applications in
bioanalytical chemistry and bionanotechnology [45,138,139]. Depending on the NP material and the
aim of the application, a variety of conjugation strategies have been exploited, ranging from the simple
deposition of the biomolecule on the NP surface [46,139], to non-covalent high affinity binding [45]
and to covalent bond formation [138,140]. The conformational versatility of αS made it possible to
exploit different properties of the associated molecules, from a disordered and highly dynamic form
to the ordered superstructure typical of fibrils. Furthermore, protein self-assembly was exploited to
fabricate ordered multi-component, supramolecular nanomaterials [46].
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Jares-Erijman and coworkers explored the possibility to develop novel reactive agents or
nanoactuators, based on the decoration of QDs with multiple copies of αS [45]. αS containing
an A90C single point mutation was conjugated to biotin via maleimide chemistry, while QDs were
capped with streptavidin. Thus, αS-QD nanoconjugates were obtained exploiting the formation of the
well-known high affinity biotin-streptavidin complex. The nanoactuators were found to accelerate the
formation of αS amyloid fibrils, both in vitro and in live cells, thereby acting as artificial nucleation
seeds. The catalytic effect was attributed to the self-assembly of the protein initiated by the high local
concentrations displayed at the surface of the NPs. The developed system could facilitate cellular
studies of amyloid formation.
The production of AuNP-biomolecule conjugates often exploits the spontaneous formation of
ligand monolayers via unique bonds between the Au surface and sulfhydryl groups of the biomolecule.
Paik and coworkers found that a thin shell of modified αS molecules conjugated to AuNPs via Au-S
bonds facilitated their deposition into a regular two-dimensional array on a glass support [138].
The obtained material constituted the basis for the production of a surface-enhanced Raman scattering
biosensor. The platform was indeed responsive to phthalocyanine tetrasulfonate, an αS ligand and
aggregation inhibitor and to metal ions forming complexes with the compound. The formation of a
uniform array of coated AuNPs was attributed to the capability of fixed αS molecules to establish
intermolecular interactions.
The αS-mediated assembly of AuNPs into hierarchical superstructures was further exploited to
fabricate a flexible, free-standing NP monolayer film useful for the development of bio-integrated
nano-devices and high-performance sensors [46] (Figure 4). Cysteine-free protein was first adsorbed
onto AuNPs (10–30 nm) and subsequently onto a polycarbonate substrate. Fibril-like protein-protein
linkages were revealed by scanning electron microscopy and β-sheet structure formation was observed
by attenuated total reflectance Fourier transform infrared spectroscopy. The conversion intoβ structures
was probably triggered by the exposure of the protein-AuNP system to chloroform, necessary to
release the film from the support. Importantly, the process was specific for αS, as the film could
not be obtained with other model protein molecules. An analogous concept was used to develop
metal NP-based organic field-effect transistors with electrical memory [139]. A closely packed AuNP
monolayer was obtained by the pH-dependent adsorption of αS-AuNP conjugates on a SiO2 surface.
Pentacene, a high-performance organic semiconductor, was finally deposited on the formed αS-AuNP
film. The use of αS proved invaluable for the optimal controllability over the hybrid material structures,
allowing to obtain highly tunable memory performance.
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αS-AuNP monolayer film through the preparation of αS-coated AuNPs, adsorption of the αS-AuNPs
onto the polycarbonate (PC) substrate and subsequent free-standing film production by αS–αS
self-assembly upon removal of the substrate with chloroform. Reproduced with permission from
Lee et al. Angew Chem. Int. Ed., 2015, 54 (15), 4571–4576,© 2020 WILEY-VCH Verlag GmbH & Co.
KGaA, Weinheim.
Another study demonstrated the possibility to produce αS-based nanocomposites as intracellular
drug delivery systems [140]. Mesoporous SNPs (~100 nm size and pore diameter of 2–3 nm) were
coated with AuNPs, previously functionalized with αS, to yield ‘raspberry-type’ particles-on-a-particle
(PoP) structures. The anticancer agent rhodamine 6G, loaded into the PoPs, could be released upon
exposure of the nanocomposite to the αS-binding cation Ca2+. Intracellular uptake of PoPs and drug
release was demonstrated with HeLa cells in the presence of intracellular Ca2+-regulating agents.
In this context, αS acted as a useful switch to open the gates of mesoporous SNPs by altering its
conformation in a Ca2+-dependent manner.
Assembly of NPs into controllable nanoobjects expands their application potential for the
development of nanoscale electronic and optical devices. Biopolymers have been shown to provide
effective means for organizing NPs into superstructures and fibrillar structures have attracted
considerable interest in this respect. For example, pea-pod-type chains of AuNPs embedded into
dielectric αS fibrils were shown to exhibit photoconductivity with visible light [141]. The unit assembly
strategy of amyloid fibril formation of αS was employed to construct anisotropic one-dimensional
chains of AuNPs within the amyloid fibrils. The necessary conformational transition of AuNP-adsorbed
molecules from the disordered to the ordered state was induced by exposure of the assembly units to
hexane or pH change. Interestingly, the morphological polymorphism of fibrillar structures obtained
in different conditions could provide a means to fabricate chains of AuNPs with diverse organization.
NP chains of Pd and Cu were also synthetized exploiting αS fibrils as biopolymeric templates [142].
Finally, αS amyloid fibrils were found to drive a helical arrangement of gold nanorods [143]. The latter
showed no apparent interaction with the monomeric protein but effective adsorption onto chiral fibril
structures via noncovalent interactions. The helical arrangement resulted in intense optical activity at
the surface plasmon resonance wavelengths, thereby constituting a novel sensing technique for the
detection of fibrils.
5. Conclusions
We surveyed research works focused on the behavior of the small protein αS at the interface with
NPs in an attempt to obtain a more defined picture of the factors that determine the protein-particle
interactions and influence the conformational transitions of the biomolecule. Through a better
understanding of αS-NP systems at the molecular level, we have moved forward towards the
possibility of designing nanomaterials with useful functionalities for applications in diverse scientific
and technological areas. A number of studies have demonstrated that it is possible to determine and
even predict howαS interacts with different nanoscale surfaces, highlighting the multiple conformations
that the polypeptide can adopt and describing how to control the interactions. It has emerged that
electrostatic forces dictate the mode of adsorption of monomeric αS to diverse nanoscale surfaces,
providing alternative anchors (the amphiphilic N-terminal or acidic C-terminal domains) for binding
to negatively or positively charged NPs. Yet, hydrophobic attraction was shown to contribute to
protein adsorption too, determining some involvement of the aggregation-promoting NAC domain.
It has been shown that certain NPs are able to modify protein aggregation, with encouraging results
regarding the possibility of redirecting the formation of neurotoxic aggregates towards more harmless
species or even of disassembling otherwise intractable amyloid fibrils. The different exposure of amino
acid residues in the monomeric, oligomeric and fibrillar states of αS may provide the basis for the
selective targeting of toxic species by NPs. Finally, the extraordinary conformational plasticity of
αS was exploited to design higher hierarchical structures that showed interesting novel physical or
Molecules 2020, 25, 5625 16 of 23
chemical attributes. The field of study continues to show extraordinary vivacity and it is expected that
new therapeutic and technological solutions will be proposed in the near future.
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